Research & Development  

Scientific Overview

Scientific Presentations

Scientific Advisory Board


Clinical Studies

Clinical Trial Participation

Clinical Trial Sites


Pre-Clinical Trials
Product Pipeline

Scientific Reports

   
Product Pipeline as of October 2007  
 

 

While the FDA ultimately determines the course and timing of clinical trials, this timeline represents an estimate as of October 2007 as to when certain research milestones could be achieved in the development of those applications.

The pipeline below is subject to change at any time and is likely to change. Actual results may differ materially. It is provided for information purposes only. Investment decisions should not be made based on the timeline. CVBT does not undertake to update the timeline on this web site. This information is only an estimate as of October 2007.

Enlarge Product Pipeline: [pdf] [jpg]

 

 

 

 


 

 

Use of this site constitutes agreement to our Terms and Conditions
and Privacy Policy. Site Design and Contents © 2008 CardioVascular BioTherapeutics, Inc. All Rights Reserved.

Some content on this site requires the free Adobe Reader.

 

7/1/2008
Dutton Associates Announces Investment Opinion: CardioVascular BioTherapeutics Maintained At Neutral Rating By Dutton Associates


6/10/2008
CVBT Inks Third Clinical Development Agreement


5/22/2008
Dr. Christopher Moore to Form ProDerm LP to Fund CVBT Wound Healing Trial


4/24/2008
CardioVascular BioTherapeutics, Inc. Funding Wound Healing Trial with R&D Partnership